Pharmacological Enhancement of Integrated Stress Response Confers Protection in Calcific Aortic Valve Disease

Libo Wang1, Xulei Duan1, Huibing Liu1

  • 1Department of Cardiology, Life Science Research Center, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.

PubMed

Insights

Nox4 and integrated stress response (ISR) signaling are implicated in calcific aortic valve disease (CAVD). Enhancing ISR pharmacologically may offer a novel therapeutic strategy for CAVD.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Integrative Physiology

Background:

  • Nox4 and integrated stress response (ISR) signaling (eIF2α/ATF4) protect against heart injury.
  • The role of Nox4 and ISR in calcific aortic valve disease (CAVD) is not well understood.

Purpose of the Study:

  • To investigate the involvement of Nox4 and ISR in CAVD pathogenesis.
  • To explore the therapeutic potential of modulating ISR in CAVD.

Main Methods:

  • Examined ATF4 and Nox4 expression in porcine aortic valve interstitial cells (AVICs) and human CAVD tissues.
  • Utilized Nox4 knockdown and overexpression models in AVICs.
  • Administered ISR activators (Guanabenz, Sephin1) in animal models of CAVD (rabbits, mice).

Main Results:

  • ATF4 and Nox4 were upregulated in CAVD.
  • Nox4 knockdown exacerbated CAVD, while overexpression suppressed it by modulating ISR.
  • ISR activators attenuated AVIC osteoblastic differentiation and mitigated CAVD in vivo.

Conclusions:

  • Nox4 and ISR play critical roles in CAVD development.
  • Pharmacological enhancement of ISR represents a promising therapeutic avenue for CAVD.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
367
Physiological Foundation of Stress01:24

Physiological Foundation of Stress

Stress triggers a coordinated physiological response involving the sympathetic nervous system (SNS) and the hypothalamic-pituitary-adrenal (HPA) axis. This dual activation ensures that the body is prepared for both immediate and prolonged stress management. The process begins with the perception of a stressor. This initial phase activates the SNS, leading to the rapid release of adrenaline (epinephrine) from the adrenal glands.
Role of the Sympathetic Nervous System
Adrenaline triggers the...
512
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K